Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1923 1
1924 1
1925 2
1928 2
1945 2
1946 7
1947 12
1948 12
1949 9
1950 5
1951 14
1952 12
1953 20
1954 16
1955 13
1956 19
1957 9
1958 6
1959 13
1960 19
1961 20
1962 27
1963 29
1964 30
1965 48
1966 59
1967 92
1968 117
1969 114
1970 129
1971 157
1972 194
1973 236
1974 256
1975 951
1976 1087
1977 1097
1978 1208
1979 1411
1980 1613
1981 1871
1982 1984
1983 2635
1984 2894
1985 3318
1986 3696
1987 4258
1988 4674
1989 6075
1990 6611
1991 7557
1992 8359
1993 9570
1994 10787
1995 12249
1996 13758
1997 15111
1998 16971
1999 19121
2000 21981
2001 24363
2002 27215
2003 30938
2004 36176
2005 40418
2006 45873
2007 50465
2008 55930
2009 60582
2010 69651
2011 79169
2012 88163
2013 96379
2014 104778
2015 113252
2016 120158
2017 127257
2018 135306
2019 146166
2020 169233
2021 190235
2022 192436
2023 188901
2024 211493
2025 231515
2026 1025
2027 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,536,199 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: 15283675
Page 1
Emerging Targets in Non-Small Cell Lung Cancer.
Liu L, Soler J, Reckamp KL, Sankar K. Liu L, et al. Int J Mol Sci. 2024 Sep 18;25(18):10046. doi: 10.3390/ijms251810046. Int J Mol Sci. 2024. PMID: 39337530 Free PMC article. Review.
Target and tissue selectivity of PROTAC degraders.
Guenette RG, Yang SW, Min J, Pei B, Potts PR. Guenette RG, et al. Chem Soc Rev. 2022 Jul 18;51(14):5740-5756. doi: 10.1039/d2cs00200k. Chem Soc Rev. 2022. PMID: 35587208 Review.
Targeted Drug Delivery: Trends and Perspectives.
Ashique S, Sandhu NK, Chawla V, Chawla PA. Ashique S, et al. Curr Drug Deliv. 2021;18(10):1435-1455. doi: 10.2174/1567201818666210609161301. Curr Drug Deliv. 2021. PMID: 34151759 Review.
Synthetic Lethality in Cancer Therapeutics: The Next Generation.
Setton J, Zinda M, Riaz N, Durocher D, Zimmermann M, Koehler M, Reis-Filho JS, Powell SN. Setton J, et al. Cancer Discov. 2021 Jul;11(7):1626-1635. doi: 10.1158/2159-8290.CD-20-1503. Epub 2021 Apr 1. Cancer Discov. 2021. PMID: 33795234 Free PMC article. Review.
Targeting the undruggables-the power of protein degraders.
Zhang C, Liu Y, Li G, Yang Z, Han C, Sun X, Sheng C, Ding K, Rao Y. Zhang C, et al. Sci Bull (Beijing). 2024 Jun 15;69(11):1776-1797. doi: 10.1016/j.scib.2024.03.056. Epub 2024 Mar 29. Sci Bull (Beijing). 2024. PMID: 38614856 Free article. Review.
Electrophilic warheads in covalent drug discovery: an overview.
Péczka N, Orgován Z, Ábrányi-Balogh P, Keserű GM. Péczka N, et al. Expert Opin Drug Discov. 2022 Apr;17(4):413-422. doi: 10.1080/17460441.2022.2034783. Epub 2022 Feb 6. Expert Opin Drug Discov. 2022. PMID: 35129005 Review.
2,536,199 results
You have reached the last available page of results. Please see the User Guide for more information.